IBSA PHARMA Recalls
15 recalls on record · March 1, 2023 to March 1, 2023 · Drugs
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for I
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for I
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for I
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for I
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Hazard: Subpotent Drug
March 1, 2023DrugsFDA
IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for I
Hazard: Subpotent Drug